Sun Pharma, India’s largest pharmaceutical company, is set to acquire Checkpoint Therapeutics for $355 million. This strategic acquisition will enhance Sun Pharma’s specialty portfolio, including UNLOXCYT, an FDA-approved treatment for advanced skin cancer, expanding its global presence in oncology treatments. Post navigation Rupee slips 46 paise against $, biggest 1-day fall in 2 weeks How these startups are growing without big teams or VC money
